| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999376 | Urologic Oncology: Seminars and Original Investigations | 2016 | 9 Pages |
Abstract
Incorporation of MRI and MRTB in PCa diagnosis and management represents a cost-effective measure at 5, 10, 15, and 20 years after initial diagnosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yannick Cerantola, Alice Dragomir, Simon Tanguay, Franck Bladou, Armen Aprikian, Wassim Kassouf,